arrow
K

Kamila Romanowski

bc centre for disease control
H指数:17
被引数:1,393

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety of tuberculosis preventive treatment among people receiving or about to initiate immunosuppressive medications: a systematic review and meta-analysis

结核病预防性治疗在接受或即将开始免疫抑制药物的人群中的安全性:一项系统评价和荟萃分析

2026-09-210
OAAI
Estimated impact of timely, guideline-adherent tuberculosis screening in primary care settings among new permanent residents to British Columbia, Canada: A population-based study

及时、符合指南的结核病筛查在加拿大不列颠哥伦比亚省新永久居民初级保健设置中的估计影响:一项基于人群的研究

2026-04-130
OAAI
Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective Analysis

治疗结局和药物相关不良事件在南非四种短程RR-TB方案中的比较:一项回顾性分析

2026-02-080
OAAI
Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial

4个月利福平与2个月双倍剂量利福平治疗结核感染的成本比较:一项2b期随机试验的事后分析

2025-09-010
OAAI
Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data
2024-11-202
OA
Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trial
2024-05-010
OAAI
Post-TB health and wellbeing
2023-04-0152
OAAI
DISCOVERY AND VALIDATION OF A PERSONALISED RISK PREDICTOR FOR INCIDENT TUBERCULOSIS IN SETTINGS AIMING TOWARDS PRE-ELIMINATION (PERISKOPE-TB)
THORAX
IF7.7
2021-01-210
PRE
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
2020-10-1956
OAAI